최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Experimental dermatology, v.31 no.11, 2022년, pp.1764 - 1778
Heim, Marjorie (Centre Mé) , Irondelle, Marie (diterrané) , Duteil, Luc (en de Mé) , Cardot‐Leccia, Nathalie (decine Molé) , Rocchi, Stéphane (culaire (C3M), Université) , Passeron, Thierry (Cô) , Tulic, Meri K. (te d'Azur, Nice, France)
AbstractPsoriasis is a chronic inflammatory disease whereby long‐term disease control remains a challenge for the patients. Latest evidence suggests that combined topical treatment with steroids and vitamin D analogue foam (Calcipotriol/Betamethasone) is efficient in long‐term management...
1 Parisi R , Symmons DPM , Griffiths CEM , Ashcroft DM . Identification and management of psoriasis and associated comorbidiTy (IMPACT) project team. global epidemiology of psoriasis: a systematic review of incidence and prevalence . J Invest Dermatol . 2013 ; 133 ( 2 ): 377 ‐ 385 . doi: 10.1038/jid.2012.339 23014338
2 Reid C , Griffiths CEM . Psoriasis and Treatment: Past, Present and Future Aspects . Acta Derm Venereol . 2020 ; 100 ( 3 ): adv00032 . doi: 10.2340/00015555-3386 31971601
3 Hu L , Bikle DD , Oda Y . Reciprocal role of vitamin D receptor on β‐catenin regulated keratinocyte proliferation and differentiation . J Steroid Biochem Mol Biol . 2014 ; 144 Pt A : 237 ‐ 241 . doi: 10.1016/j.jsbmb.2013.11.002 24239508
5 Lebwohl M , Kircik L , Lacour JP , et al. Twice‐weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO‐LONG trial) . J Am Acad Dermatol . 2021 ; 84 ( 5 ): 1269 ‐ 1277 . doi: 10.1016/j.jaad.2020.09.037 32950546
6 Fabbrocini G , de Simone C , Dapavo P , Malagoli P , Martella A , Calzavara‐Pinton P . Long‐term maintenance treatment of psoriasis: the role of calcipotriol/betamethasone dipropionate aerosol foam in clinical practice . J Dermatolog Treat . 2022 ; 4 : 1 ‐ 8 . doi: 10.1080/09546634.2021.1998310
7 Lebwohl MG , Papp KA , Mørch MH , Bernasconi MYJ , Warren RB . Long‐term proactive treatment of plaque psoriasis with calcipotriene/betamethasone dipropionate foam prolongs remission and reduces relapses irrespective of patient baseline characteristics . DermatolTher . 2021 ; 11 ( 5 ): 1657 ‐ 1665 . doi: 10.1007/s13555-021-00585-x
8 Amat‐Samaranch V , Puig L . Safety of calcipotriene and betamethasone dipropionate foam for the treatment of psoriasis . Expert Opin Drug Saf . 2020 ; 19 ( 4 ): 423 ‐ 432 . doi: 10.1080/14740338.2020.1749594 32243212
9 Jalili A , Bewley A , Sticherling M , Stein GL . Short term and long‐term efficacy of calcipotriene/betamethasone dipropionate foam combination . Clin Cosmet Investig Dermatol . 2022 ; 2 ( 15 ): 809 ‐ 814 . doi: 10.2147/CCID.S361884
10 di Meglio P , Villanova F , Navarini AA , et al. Targeting CD8+ T cells prevents psoriasis development . J Allergy Clin Immunol . 2016 ; 138 ( 1 ): 274 ‐ 276.e6 . doi: 10.1016/j.jaci.2015.10.046 26782974
11 Hijnen D , Knol EF , Gent YY , et al. CD8+ T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN‐γ, IL‐13, IL‐17, and IL‐22 . J Invest Dermatol . 2013 ; 133 ( 4 ): 973 ‐ 979 . doi: 10.1038/jid.2012.456 23223131
12 Lin AM , Rubin CJ , Khandpur R , et al. Mast cells and neutrophils release IL‐17 through extracellular trap formation in psoriasis . J Immunol . 2011 ; 187 ( 1 ): 490 ‐ 500 . doi: 10.4049/jimmunol.1100123 21606249
13 Chiang CC , Cheng WJ , Korinek M , Lin CY , Hwang TL . Neutrophils in Psoriasis . Front Immunol . 2019 ; 10 : 2376 . doi: 10.3389/fimmu.2019.02376 31649677
14 Lovato P , Norsgaard H , Tokura Y , Røpke MA . Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell‐Th17 cell axis in psoriasis . J Dermatol Sci . 2016 ; 81 ( 3 ): 153 ‐ 164 . doi: 10.1016/j.jdermsci.2015.12.009 26794805
15 Fujiyama T , Ito T , Umayahara T , et al. Topical application of a vitamin D3 analogue and corticosteroid to psoriasis plaques decreases skin infiltration of TH17 cells and their ex vivo expansion . J Allergy Clin Immunol . 2016 ; 138 ( 2 ): 517 ‐ 528 . doi: 10.1016/j.jaci.2016.03.048 27315769
16 Kryczek I , Bruce AT , Gudjonsson JE , et al. Induction of IL‐17 + T cell trafficking and development by IFN‐γ: mechanism and pathological relevance in psoriasis . J Immunol . 2008 ; 181 ( 7 ): 4733 ‐ 4741 . doi: 10.4049/jimmunol.181.7.4733 18802076
17 Austin LM , Ozawa M , Kikuchi T , Walters IB , Krueger JG . The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon‐γ, interleukin‐2, and tumor necrosis factor‐α, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: A type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients . J Invest Dermatol . 1999 ; 113 ( 5 ): 752 ‐ 759 . doi: 10.1046/j.1523-1747.1999.00749.x 10571730
18 Ottaviani C , Nasorri F , Bedini C , de Pità O , Girolomoni G , Cavani A . CD56brightCD16‐ NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation . Eur J Immunol . 2006 ; 36 ( 1 ): 118 ‐ 128 . doi: 10.1002/eji.200535243 16323244
19 Cai Y , Shen X , Ding C , et al. Pivotal role of dermal IL‐17‐producing γδ T cells in skin inflammation . Immunity . 2011 ; 35 ( 4 ): 596 ‐ 610 . doi: 10.1016/j.immuni.2011.08.001 21982596
20 Aratani Y . Myeloperoxidase: its role for host defense, inflammation, and neutrophil function . Arch Biochem Biophys . 2018 ; 640 : 47 ‐ 52 . doi: 10.1016/j.abb.2018.01.004 29336940
21 Dilek N , Dilek AR , Taşkın Y , Erkinüresin T , Yalçın Ö , Saral Y . Contribution of myeloperoxidase and inducible nitric oxide synthase to pathogenesis of psoriasis . Postepy Dermatol Alergol . 2016 ; 33 ( 6 ): 435 ‐ 439 . doi: 10.5114/ada.2016.63882 28035220
22 Krueger J , Clark JD , Suárez‐Fariñas M , et al. Tofacitinib attenuates pathologic immune pathways in patients with psoriasis: a randomized phase 2 study . J Allergy Clin Immunol . 2016 ; 137 ( 4 ): 1079 ‐ 1090 . doi: 10.1016/j.jaci.2015.12.1318 27059729
23 Samarasekera E , Sawyer L , Parnham J , Smith CH . Assessment and management of psoriasis: summary of NICE guidance . BMJ . 2012 ; 345 ( 7880 ): e6712 . doi: 10.1136/bmj.e6712 23097521
24 Maroto‐Morales D , Montero‐Vilchez T , Arias‐Santiago S . Study of skin barrier function in psoriasis: the impact of emollients . Life . 2021 ; 11 ( 7 ): 651 . doi: 10.3390/life11070651 34357023
25 Gunderson AJ , Mohammed J , Horvath FJ , Podolsky MA , Anderson CR , Glick AB . CD8+ T cells mediate RAS‐induced psoriasis‐like skin inflammation through IFN‐γ . J Invest Dermatol . 2013 ; 133 ( 4 ): 955 ‐ 963 . doi: 10.1038/jid.2012.390 23151849
26 Yan K , Han L , Deng H , et al. The distinct role and regulatory mechanism of IL‐17 and IFN‐γ in the initiation and development of plaque vs guttate psoriasis . J Dermatol Sci . 2018 ; 92 ( 1 ): 106 ‐ 113 . doi: 10.1016/j.jdermsci.2018.07.001 30072243
27 Ortega C , Fernández‐A S , Carrillo JM , et al. IL‐17‐producing CD8 + T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17‐related cytokines . J Leuk Biol . 2009 ; 86 ( 2 ): 435 ‐ 443 . doi: 10.1189/jlb.0109046
28 Tajima M , Wakita D , Satoh T , Kitamura H , Nishimura T . IL‐17/IFN‐γ double producing CD8 + T (Tc17/IFN‐γ) cells: A novel cytotoxic T‐cell subset converted from Tc17 cells by IL‐12 . Int Immunol . 2011 ; 23 ( 12 ): 751 ‐ 759 . doi: 10.1093/intimm/dxr086 22039016
29 Kumaresan PR , da Silva TA , Kontoyiannis DP . Methods of controlling invasive fungal infections using CD8+ T cells . Front Immunol . 2018 ; 8 : 1939 . doi: 10.3389/fimmu.2017.01939 29358941
30 Dyring‐Andersen B , Honoré TV Madelung A et al.. Interleukin (IL)‐17A and IL‐22‐producing neutrophils in psoriatic skin. Brit Brit J Dermatol 2017 ; 177 ( 6 ): e321 ‐ e322 . 10.1111/bjd.15533 28369663
31 Brembilla NC , Senra L , Boehncke WH . The IL‐17 family of cytokines in psoriasis: IL‐17A and beyond . Front Immunol . 2018 ; 9 : 1682 . doi: 10.3389/fimmu.2018.01682 30127781
32 Reich K , Papp KA , Matheson RT , et al. Evidence that a neutrophil‐keratinocyte crosstalk is an early target of IL‐17A inhibition in psoriasis . Exp Dermatol . 2015 ; 24 ( 7 ): 529 ‐ 535 . doi: 10.1111/exd.12710 25828362
33 Lambert S , Hambro CA , Johnston A , et al. Neutrophil extracellular traps induce human Th17 cells: effect of psoriasis‐associated TRAF3IP2 genotype . J Invest Dermatol . 2019 ; 139 ( 6 ): 1245 ‐ 1253 . doi: 10.1016/j.jid.2018.11.021 30528823
34 Toichi E , Tachibana T , Furukawa F . Rapid improvement of psoriasis vulgaris during drug‐induced agranulocytosis . J Am Acad Dermatol . 2000 ; 43 ( 2 Pt 2 ): 391 ‐ 395 . doi: 10.1067/mjd.2000.103264 10901732
35 Sheu JS , Divito SJ , Enamandram M , Merola JF . Dapsone therapy for pustular psoriasis: case series and review of the literature . Dermatology . 2016 ; 232 ( 1 ): 97 ‐ 101 . doi: 10.1159/000431171 26465742
36 Slominski AT , Kim T , Takeda Y , et al. RORα and ROR γ are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20‐hydroxy‐ and 20,23‐dihydroxyvitamin D . FASEB J . 2014 ; 28 ( 7 ): 2775 ‐ 2789 . doi: 10.1096/fj.13-242040 24668754
37 Bernhard S , Hug S , Stratmann AEP , et al. Interleukin 8 elicits rapid physiological changes in neutrophils that are altered by inflammatory conditions . JInnate Immunity . 2021 ; 13 ( 4 ): 225 ‐ 241 . doi: 10.1159/000514885 33857948
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 APC(Article Processing Charge)를 지불한 논문에 한하여 자유로운 이용이 가능한, hybrid 저널에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.